Sep 2026
Abstract A070: Clinical application of functional precision medicine for pancreatic cancer enables personalized treatment prioritization and identification of RAS-targeted combinations
Treatment of advanced pancreatic cancer relies on empirically selected combinations yielding response rates of 20 to 40%. Although KRAS mutations are present in over 90% of these cases, responses to KRAS-targeted therapies vary, highlighting the need for functional approaches to identify optimal therapies. Optim....
Edward Kai-Hua. Chow, Masturah Mohamed Abdul Rashid, Lydia Ogrodzinski et al.
· Cancer Research · 0 citations